|
original article |
Date |
Title |
Authors Max. 6 Authors |
1 |
[GO] |
2024―Jul―25 |
Epi-Cyclophellitol Cyclosulfate, a Mechanism-Based Endoplasmic Reticulum α-Glucosidase II Inhibitor, Blocks Replication of SARS-CoV-2 and Other Coronaviruses |
Melissa Thaler, Tim P. Ofman, Ken Kok, Jurriaan J. A. Heming, Elisha Moran, Isabelle Pickles, Anouk A. Leijs, Adrianus M. C. H. van den Nieuwendijk, Richard J. B. H. N. van den Berg, Gijs Ruijgrok, Zachary Armstrong, Clarisse Salgado-Benvindo, Dennis K. Ninaber, Eric J. Snijder, Constant A. A. van Boeckel, Marta Artola, Gideon J. Davies, Herman S. Overkleeft, Martijn J. van Hemert |
2 |
[GO] |
2024―Jul―12 |
Rolling on the Chip: SARS-CoV-2 Detection by DNA Motors |
Longjiang Ding, Na Liu |
3 |
[GO] |
2024―May―21 |
Rolosense: Mechanical Detection of SARS-CoV-2 Using a DNA-Based Motor |
Selma Piranej, Luona Zhang, Alisina Bazrafshan, Mariana Marin, Gregory B. Melikian, Khalid Salaita |
4 |
[GO] |
2024―Jan―17 |
Pseudo-Luciferase Activity of the SARS-CoV-2 Spike Protein for Cypridina Luciferin |
Ryo Nishihara, Hisham M. Dokainish, Yoshiki Kihara, Hiroki Ashiba, Yuji Sugita, Ryoji Kurita |
5 |
[GO] |
2023―Nov―02 |
Long COVID Researchers Are on the Hunt for Causes and Cures |
Shi En Kim |
6 |
[GO] |
2023―Sep―21 |
Spike Protein Mutation-Induced Changes in the Kinetic and Thermodynamic Behavior of Its Receptor Binding Domains Explain Their Higher Propensity to Attain Open States in SARS-CoV-2 Variants of Concern |
Jasdeep Singh, Shubham Vashishtha, Bishwajit Kundu |
7 |
[GO] |
2023―Jul―25 |
Naturally Occurring Mutations of SARS-CoV-2 Main Protease Confer Drug Resistance to Nirmatrelvir |
Yanmei Hu, Eric M. Lewandowski, Haozhou Tan, Xiaoming Zhang, Ryan T. Morgan, Xiujun Zhang, Lian M. C. Jacobs, Shane G. Butler, Maura V. Gongora, John Choy, Xufang Deng, Yu Chen, Jun Wang |
8 |
[GO] |
2023―Jun―07 |
Host Cell Membrane Capture by the SARS-CoV-2 Spike Protein Fusion Intermediate |
Rui Su, Jin Zeng, Tara C. Marcink, Matteo Porotto, Anne Moscona, Ben O’Shaughnessy |
9 |
[GO] |
2023―May―10 |
Lectin Fingerprinting Distinguishes Antibody Neutralization in SARS-CoV-2 |
Michael G. Wuo, Amanda E. Dugan, Melanie Halim, Blake M. Hauser, Jared Feldman, Timothy M. Caradonna, Shuting Zhang, Lauren E. Pepi, Caroline Atyeo, Stephanie Fischinger, Galit Alter, Wilfredo F. Garcia-Beltran, Parastoo Azadi, Deb Hung, Aaron G. Schmidt, Laura L. Kiessling |
10 |
[GO] |
2023―Apr―07 |
Development of a Manufacturing Process toward the Convergent Synthesis of the COVID-19 Antiviral Ensitrelvir |
Takahiro Kawajiri, Akihito Kijima, Atsuhiro Iimuro, Eisaku Ohashi, Katsuya Yamakawa, Kazushi Agura, Kengo Masuda, Kensuke Kouki, Koji Kasamatsu, Shuichi Yanagisawa, Sho Nakashima, Setsuya Shibahara, Takashi Toyota, Takafumi Higuchi, Takahiro Suto, Tadashi Oohara, Toshikatsu Maki, Naoto Sahara, Nobuaki Fukui, Hisayuki Wakamori, Hidaka Ikemoto, Hiroaki Murakami, Hiroyasu Ando, Masahiro Hosoya, Mizuki Sato, Yusuke Suzuki, Yuta Nakagawa, Yuto Unoh, Yoichi Hirano, Yoshitomo Nagasawa, Satoshi Goda, Takafumi Ohara, Takayuki Tsuritani |
11 |
[GO] |
2023―Mar―21 |
SARS-CoV-2 Mpro Protease Variants of Concern Display Altered Viral Substrate and Cell Host Target Galectin-8 Processing but Retain Sensitivity toward Antivirals |
Sizhu Amelia Chen, Elena Arutyunova, Jimmy Lu, Muhammad Bashir Khan, Wioletta Rut, Mikolaj Zmudzinski, Shima Shahbaz, Jegan Iyyathurai, Eman W. Moussa, Zoe Turner, Bing Bai, Tess Lamer, James A. Nieman, John C. Vederas, Olivier Julien, Marcin Drag, Shokrollah Elahi, Howard S. Young, M. Joanne Lemieux |
12 |
[GO] |
2023―Mar―20 |
Computational Protein Design for COVID-19 Research and Emerging Therapeutics |
Parismita Kalita, Timir Tripathi, Aditya K. Padhi |
13 |
[GO] |
2023―Feb―16 |
O-Linked Sialoglycans Modulate the Proteolysis of SARS-CoV-2 Spike and Likely Contribute to the Mutational Trajectory in Variants of Concern |
Edgar Gonzalez-Rodriguez, Mia Zol-Hanlon, Ganka Bineva-Todd, Andrea Marchesi, Mark Skehel, Keira E. Mahoney, Chloë Roustan, Annabel Borg, Lucia Di Vagno, Svend Kjær, Antoni G. Wrobel, Donald J. Benton, Philipp Nawrath, Sabine L. Flitsch, Dhira Joshi, Andrés Manuel González-Ramírez, Katalin A. Wilkinson, Robert J. Wilkinson, Emma C. Wall, Ramón Hurtado-Guerrero, Stacy A. Malaker, Benjamin Schumann |
14 |
[GO] |
2023―Feb―08 |
In Silico Discovery of Small Molecule Modulators Targeting the Achilles’ Heel of SARS-CoV-2 Spike Protein |
Qing Wang, Fanhao Meng, Yuting Xie, Wei Wang, Yumin Meng, Linjie Li, Tao Liu, Jianxun Qi, Xiaodan Ni, Sanduo Zheng, Jianhui Huang, Niu Huang |
15 |
[GO] |
2023―Jan―25 |
Development of Highly Potent Noncovalent Inhibitors of SARS-CoV-2 3CLpro |
Ningke Hou, Lei Shuai, Lijing Zhang, Xuping Xie, Kaiming Tang, Yunkai Zhu, Yin Yu, Wenyi Zhang, Qiaozhu Tan, Gongxun Zhong, Zhiyuan Wen, Chong Wang, Xijun He, Hong Huo, Haishan Gao, You Xu, Jing Xue, Chen Peng, Jing Zou, Craig Schindewolf, Vineet Menachery, Wenji Su, Youlang Yuan, Zuyuan Shen, Rong Zhang, Shuofeng Yuan, Hongtao Yu, Pei-Yong Shi, Zhigao Bu, Jing Huang, Qi Hu |
16 |
[GO] |
2023―Jan―13 |
A Selective SARS-CoV-2 Host-Directed Antiviral Targeting Stress Response to Reactive Oxygen Species |
Cong Tang, Ana R. Coelho, Maria Rebelo, Hannah Kiely-Collins, Tânia Carvalho, Gonçalo J. L. Bernardes |
17 |
[GO] |
2023―Jan―02 |
Robust Covalent Aptamer Strategy Enables Sensitive Detection and Enhanced Inhibition of SARS-CoV-2 Proteins |
Dan Wang, Jing Zhang, Zhiyong huang, Yuhang Yang, Ting Fu, Yu Yang, Yifan Lyu, Jianhui Jiang, Liping Qiu, Zehui Cao, Xiaobing Zhang, Qimin You, Yuankui Lin, Zilong Zhao, Weihong Tan |
18 |
[GO] |
2022―Mar―29 |
Synthetic Heparan Sulfate Mimetic Pixatimod (PG545) Potently Inhibits SARS-CoV-2 by Disrupting the Spike-ACE2 Interaction |
Scott E. Guimond, Courtney J. Mycroft-West, Neha S. Gandhi, Julia A. Tree, Thuy T. Le, C. Mirella Spalluto, Maria V. Humbert, Karen R. Buttigieg, Naomi Coombes, Michael J. Elmore, Matthew Wand, Kristina Nyström, Joanna Said, Yin Xiang Setoh, Alberto A. Amarilla, Naphak Modhiran, Julian D. J. Sng, Mohit Chhabra, Paul R. Young, Daniel J. Rawle, Marcelo A. Lima, Edwin A. Yates, Richard Karlsson, Rebecca L. Miller, Yen-Hsi Chen, Ieva Bagdonaite, Zhang Yang, James Stewart, Dung Nguyen, Stephen Laidlaw, Edward Hammond, Keith Dredge, Tom M. A. Wilkinson, Daniel Watterson, Alexander A. Khromykh, Andreas Suhrbier, Miles W. Carroll, Edward Trybala, Tomas Bergström, Vito Ferro, Mark A. Skidmore, Jeremy E. Turnbull |
19 |
[GO] |
2022―Mar―23 |
How Early-Career Scientists Responded with Resiliency to the Space Created by the COVID-19 Pandemic |
Fun Man Fung, Safia Z. Jilani, Monica L. Ohnsorg, Rebecca L. Pinals, Mohit Saraf, Joshua Tropp, Peter Carlton |
20 |
[GO] |
2022―Feb―14 |
Mucins Inhibit Coronavirus Infection in a Glycan-Dependent Manner |
Casia L. Wardzala, Amanda M. Wood, David M. Belnap, Jessica R. Kramer |
21 |
[GO] |
2022―Feb―02 |
Evaluation of SARS-CoV-2 Main Protease Inhibitors Using a Novel Cell-Based Assay |
Wenyue Cao, Chia-Chuan Dean Cho, Zhi Zachary Geng, Namir Shaabani, Xinyu R. Ma, Erol C. Vatansever, Yugendar R. Alugubelli, Yuying Ma, Sankar P. Chaki, William H. Ellenburg, Kai S. Yang, Yuchen Qiao, Robert Allen, Benjamin W. Neuman, Henry Ji, Shiqing Xu, Wenshe Ray Liu |
22 |
[GO] |
2021―Nov―22 |
Enzymatic Catalysts to Combat COVID-19 |
Isita Jhulki, Jordan L. Meier |
23 |
[GO] |
2021―Nov―04 |
Probing Affinity, Avidity, Anticooperativity, and Competition in Antibody and Receptor Binding to the SARS-CoV-2 Spike by Single Particle Mass Analyses |
Victor Yin, Szu-Hsueh Lai, Tom G. Caniels, Philip J. M. Brouwer, Mitch Brinkkemper, Yoann Aldon, Hejun Liu, Meng Yuan, Ian A. Wilson, Rogier W. Sanders, Marit J. van Gils, Albert J. R. Heck |
24 |
[GO] |
2021―Oct―29 |
Engineered Ribosyl-1-Kinase Enables Concise Synthesis of Molnupiravir, an Antiviral for COVID-19 |
John A. McIntosh, Tamas Benkovics, Steven M. Silverman, Mark A. Huffman, Jongrock Kong, Peter E. Maligres, Tetsuji Itoh, Hao Yang, Deeptak Verma, Weilan Pan, Hsing-I Ho, Jonathan Vroom, Anders M. Knight, Jessica A. Hurtak, Artis Klapars, Anna Fryszkowska, William J. Morris, Neil A. Strotman, Grant S. Murphy, Kevin M. Maloney, Patrick S. Fier |
25 |
[GO] |
2021―Sep―15 |
Nanopore Dwell Time Analysis Permits Sequencing and Conformational Assignment of Pseudouridine in SARS-CoV-2 |
Aaron M. Fleming, Nicole J. Mathewson, Shereen A. Howpay Manage, Cynthia J. Burrows |
26 |
[GO] |
2021―Jul―21 |
Polymersomes Decorated with the SARS-CoV-2 Spike Protein Receptor-Binding Domain Elicit Robust Humoral and Cellular Immunity |
Lisa R. Volpatti, Rachel P. Wallace, Shijie Cao, Michal M. Raczy, Ruyi Wang, Laura T. Gray, Aaron T. Alpar, Priscilla S. Briquez, Nikolaos Mitrousis, Tiffany M. Marchell, Maria Stella Sasso, Mindy Nguyen, Aslan Mansurov, Erica Budina, Ani Solanki, Elyse A. Watkins, Mathew R. Schnorenberg, Andrew C. Tremain, Joseph W. Reda, Vlad Nicolaescu, Kevin Furlong, Steve Dvorkin, Shann S. Yu, Balaji Manicassamy, James L. LaBelle, Matthew V. Tirrell, Glenn Randall, Marcin Kwissa, Melody A. Swartz, Jeffrey A. Hubbell |
27 |
[GO] |
2021―Jun―30 |
CD209L/L-SIGN and CD209/DC-SIGN Act as Receptors for SARS-CoV-2 |
Razie Amraei, Wenqing Yin, Marc A. Napoleon, Ellen L. Suder, Jacob Berrigan, Qing Zhao, Judith Olejnik, Kevin Brown Chandler, Chaoshuang Xia, Jared Feldman, Blake M. Hauser, Timothy M. Caradonna, Aaron G. Schmidt, Suryaram Gummuluru, Elke Mühlberger, Vipul Chitalia, Catherine E. Costello, Nader Rahimi |
28 |
[GO] |
2021―Jun―18 |
Discovery of SARS-CoV-2 Papain-like Protease Inhibitors through a Combination of High-Throughput Screening and a FlipGFP-Based Reporter Assay |
Chunlong Ma, Michael Dominic Sacco, Zilei Xia, George Lambrinidis, Julia Alma Townsend, Yanmei Hu, Xiangzhi Meng, Tommy Szeto, Mandy Ba, Xiujun Zhang, Maura Gongora, Fushun Zhang, Michael Thomas Marty, Yan Xiang, Antonios Kolocouris, Yu Chen, Jun Wang |
29 |
[GO] |
2021―Jun―18 |
An mRNA SARS-CoV-2 Vaccine Employing Charge-Altering Releasable Transporters with a TLR-9 Agonist Induces Neutralizing Antibodies and T Cell Memory |
Ole A. W. Haabeth, Julian J. K. Lohmeyer, Adrienne Sallets, Timothy R. Blake, Idit Sagiv-Barfi, Debra K. Czerwinski, Blaine McCarthy, Abigail E. Powell, Paul A. Wender, Robert M. Waymouth, Ronald Levy |
30 |
[GO] |
2021―Jun―03 |
Heparan Sulfate Proteoglycans as Attachment Factor for SARS-CoV-2 |
Lin Liu, Pradeep Chopra, Xiuru Li, Kim M. Bouwman, S. Mark Tompkins, Margreet A. Wolfert, Robert P. de Vries, Geert-Jan Boons |
31 |
[GO] |
2021―May―27 |
Discovery of Cyclic Peptide Ligands to the SARS-CoV-2 Spike Protein Using mRNA Display |
Alexander Norman, Charlotte Franck, Mary Christie, Paige M. E. Hawkins, Karishma Patel, Anneliese S. Ashhurst, Anupriya Aggarwal, Jason K. K. Low, Rezwan Siddiquee, Caroline L. Ashley, Megan Steain, James A. Triccas, Stuart Turville, Joel P. Mackay, Toby Passioura, Richard J. Payne |
32 |
[GO] |
2021―Apr―19 |
Molecular Aspects Concerning the Use of the SARS-CoV-2 Receptor Binding Domain as a Target for Preventive Vaccines |
Yury Valdes-Balbin, Darielys Santana-Mederos, Françoise Paquet, Sonsire Fernandez, Yanet Climent, Fabrizio Chiodo, Laura Rodríguez, Belinda Sanchez Ramirez, Kalet Leon, Tays Hernandez, Lila Castellanos-Serra, Raine Garrido, Guang-Wu Chen, Dagmar Garcia-Rivera, Daniel G. Rivera, Vicente Verez-Bencomo |
33 |
[GO] |
2021―Apr―16 |
Simeprevir Potently Suppresses SARS-CoV-2 Replication and Synergizes with Remdesivir |
Ho Sing Lo, Kenrie Pui Yan Hui, Hei-Ming Lai, Xu He, Khadija Shahed Khan, Simranjeet Kaur, Junzhe Huang, Zhongqi Li, Anthony K. N. Chan, Hayley Hei-Yin Cheung, Ka-Chun Ng, John Chi Wang Ho, Yu Wai Chen, Bowen Ma, Peter Man-Hin Cheung, Donghyuk Shin, Kaidao Wang, Meng-Hsuan Lee, Barbara Selisko, Cecilia Eydoux, Jean-Claude Guillemot, Bruno Canard, Kuen-Phon Wu, Po-Huang Liang, Ivan Dikic, Zhong Zuo, Francis K. L. Chan, David S. C. Hui, Vincent C. T. Mok, Kam-Bo Wong, Chris Ka Pun Mok, Ho Ko, Wei Shen Aik, Michael Chi Wai Chan, Wai-Lung Ng |
34 |
[GO] |
2021―Apr―06 |
Modifications in an Emergency: The Role of N1-Methylpseudouridine in COVID-19 Vaccines |
Kellie D. Nance, Jordan L. Meier |
35 |
[GO] |
2021―Apr―02 |
Native-like SARS-CoV-2 Spike Glycoprotein Expressed by ChAdOx1 nCoV-19/AZD1222 Vaccine |
Yasunori Watanabe, Luiza Mendonça, Elizabeth R. Allen, Andrew Howe, Mercede Lee, Joel D. Allen, Himanshi Chawla, David Pulido, Francesca Donnellan, Hannah Davies, Marta Ulaszewska, Sandra Belij-Rammerstorfer, Susan Morris, Anna-Sophia Krebs, Wanwisa Dejnirattisai, Juthathip Mongkolsapaya, Piyada Supasa, Gavin R. Screaton, Catherine M. Green, Teresa Lambe, Peijun Zhang, Sarah C. Gilbert, Max Crispin |
36 |
[GO] |
2021―Mar―31 |
Assessing Antigen Structural Integrity through Glycosylation Analysis of the SARS-CoV-2 Viral Spike |
Juliane Brun, Snežana Vasiljevic, Bevin Gangadharan, Mario Hensen, Anu V. Chandran, Michelle L. Hill, J.L. Kiappes, Raymond A. Dwek, Dominic S. Alonzi, Weston B. Struwe, Nicole Zitzmann |
37 |
[GO] |
2021―Mar―29 |
A Comprehensive Review of the Global Efforts on COVID-19 Vaccine Development |
Yingzhu Li, Rumiana Tenchov, Jeffrey Smoot, Cynthia Liu, Steven Watkins, Qiongqiong Zhou |
38 |
[GO] |
2021―Mar―24 |
Synthetic Siglec-9 Agonists Inhibit Neutrophil Activation Associated with COVID-19 |
Corleone S. Delaveris, Aaron J. Wilk, Nicholas M. Riley, Jessica C. Stark, Samuel S. Yang, Angela J. Rogers, Thanmayi Ranganath, Kari C. Nadeau, Catherine A. Blish, Carolyn R. Bertozzi |
39 |
[GO] |
2021―Mar―03 |
Potent SARS-CoV-2 Direct-Acting Antivirals Provide an Important Complement to COVID-19 Vaccines |
Stephen Pelly, Dennis Liotta |
40 |
[GO] |
2021―Feb―22 |
Potent Noncovalent Inhibitors of the Main Protease of SARS-CoV-2 from Molecular Sculpting of the Drug Perampanel Guided by Free Energy Perturbation Calculations |
Chun-Hui Zhang, Elizabeth A. Stone, Maya Deshmukh, Joseph A. Ippolito, Mohammad M. Ghahremanpour, Julian Tirado-Rives, Krasimir A. Spasov, Shuo Zhang, Yuka Takeo, Shalley N. Kudalkar, Zhuobin Liang, Farren Isaacs, Brett Lindenbach, Scott J. Miller, Karen S. Anderson, William L. Jorgensen |
41 |
[GO] |
2021―Jan―15 |
Handheld Point-of-Care System for Rapid Detection of SARS-CoV-2 Extracted RNA in under 20 min |
Jesus Rodriguez-Manzano, Kenny Malpartida-Cardenas, Nicolas Moser, Ivana Pennisi, Matthew Cavuto, Luca Miglietta, Ahmad Moniri, Rebecca Penn, Giovanni Satta, Paul Randell, Frances Davies, Frances Bolt, Wendy Barclay, Alison Holmes, Pantelis Georgiou |
42 |
[GO] |
2021―Jan―15 |
Correction to “The SARS-COV-2 Spike Protein Binds Sialic Acids, and Enables Rapid Detection in a Lateral Flow Point of Care Diagnostic Device” |
Alexander Baker, Sarah-Jane Richards, Thomas Congdon, Muhammad Hasan, Collette Guy, Alexander Zwetsloot, Angelo Gallo, Józef Lewandowski, Phillip Stansfeld, Anne Straube, Marc Walker, Simona Chessa, Giulia Pergolizzi, Simone Dedola, Robert Field, Matthew Gibson |
43 |
[GO] |
2021―Jan―08 |
Modeling the Binding Mechanism of Remdesivir, Favilavir, and Ribavirin to SARS-CoV-2 RNA-Dependent RNA Polymerase |
Fabian Byléhn, Cintia A. Menéndez, Gustavo R. Perez-Lemus, Walter Alvarado, Juan J. de Pablo |
44 |
[GO] |
2021―Jan―06 |
A Single Immunization with Spike-Functionalized Ferritin Vaccines Elicits Neutralizing Antibody Responses against SARS-CoV-2 in Mice |
Abigail E. Powell, Kaiming Zhang, Mrinmoy Sanyal, Shaogeng Tang, Payton A. Weidenbacher, Shanshan Li, Tho D. Pham, John E. Pak, Wah Chiu, Peter S. Kim |
45 |
[GO] |
2020―Dec―18 |
De Novo Discovery of High-Affinity Peptide Binders for the SARS-CoV-2 Spike Protein |
Sebastian Pomplun, Muhammad Jbara, Anthony J. Quartararo, Genwei Zhang, Joseph S. Brown, Yen-Chun Lee, Xiyun Ye, Stephanie Hanna, Bradley L. Pentelute |
46 |
[GO] |
2020―Oct―21 |
SARS-CoV-2 Proteome Microarray for Mapping COVID-19 Antibody Interactions at Amino Acid Resolution |
Hongye Wang, Xian Wu, Xiaomei Zhang, Xin Hou, Te Liang, Dan Wang, Fei Teng, Jiayu Dai, Hu Duan, Shubin Guo, Yongzhe Li, Xiaobo Yu |
47 |
[GO] |
2020―Oct―12 |
Fighting COVID-19 Using Molecular Dynamics Simulations |
Pablo R. Arantes, Aakash Saha, Giulia Palermo |
48 |
[GO] |
2020―Oct―02 |
New Chemical Modalities Enabling Specific RNA Targeting and Degradation: Application to SARS-CoV-2 RNA |
Audrey Di Giorgio, Maria Duca |
49 |
[GO] |
2020―Sep―30 |
Targeting the SARS-CoV-2 RNA Genome with Small Molecule Binders and Ribonuclease Targeting Chimera (RIBOTAC) Degraders |
Hafeez S. Haniff, Yuquan Tong, Xiaohui Liu, Jonathan L. Chen, Blessy M. Suresh, Ryan J. Andrews, Jake M. Peterson, Collin A. O’Leary, Raphael I. Benhamou, Walter N. Moss, Matthew D. Disney |
50 |
[GO] |
2020―Sep―23 |
Beyond Shielding: The Roles of Glycans in the SARS-CoV-2 Spike Protein |
Lorenzo Casalino, Zied Gaieb, Jory A. Goldsmith, Christy K. Hjorth, Abigail C. Dommer, Aoife M. Harbison, Carl A. Fogarty, Emilia P. Barros, Bryn C. Taylor, Jason S. McLellan, Elisa Fadda, Rommie E. Amaro |
51 |
[GO] |
2020―Sep―23 |
The SARS-COV-2 Spike Protein Binds Sialic Acids and Enables Rapid Detection in a Lateral Flow Point of Care Diagnostic Device |
Alexander N. Baker, Sarah-Jane Richards, Collette S. Guy, Thomas R. Congdon, Muhammad Hasan, Alexander J. Zwetsloot, Angelo Gallo, Józef R. Lewandowski, Phillip J. Stansfeld, Anne Straube, Marc Walker, Simona Chessa, Giulia Pergolizzi, Simone Dedola, Robert A. Field, Matthew I. Gibson |
52 |
[GO] |
2020―Sep―11 |
COVID-19 Pandemic Has Spurred Materials Researchers to Develop Antiviral Masks |
Dinsa Sachan |
53 |
[GO] |
2020―Jul―21 |
Principles Learned from the International Race to Develop a Safe and Effective COVID-19 Vaccine |
Ariel H. Thames, Kristy L. Wolniak, Samuel I. Stupp, Michael C. Jewett |
54 |
[GO] |
2020―Jun―16 |
Correction to Remdesivir: A Review of Its Discovery and Development Leading to Human Clinical Trials for Treatment of COVID-19 |
Richard T. Eastman, Jacob S. Roth, Kyle R. Brimacombe, Anton Simeonov, Min Shen, Samarjit Patnaik, Matthew D. Hall |
55 |
[GO] |
2020―May―04 |
Remdesivir: A Review of Its Discovery and Development Leading to Emergency Use Authorization for Treatment of COVID-19 |
Richard T. Eastman, Jacob S. Roth, Kyle R. Brimacombe, Anton Simeonov, Min Shen, Samarjit Patnaik, Matthew D. Hall |
56 |
[GO] |
2020―Apr―30 |
Assay Techniques and Test Development for COVID-19 Diagnosis |
Linda J. Carter, Linda V. Garner, Jeffrey W. Smoot, Yingzhu Li, Qiongqiong Zhou, Catherine J. Saveson, Janet M. Sasso, Anne C. Gregg, Divya J. Soares, Tiffany R. Beskid, Susan R. Jervey, Cynthia Liu |
57 |
[GO] |
2020―Mar―12 |
Research and Development on Therapeutic Agents and Vaccines for COVID-19 and Related Human Coronavirus Diseases |
Cynthia Liu, Qiongqiong Zhou, Yingzhu Li, Linda V. Garner, Steve P. Watkins, Linda J. Carter, Jeffrey Smoot, Anne C. Gregg, Angela D. Daniels, Susan Jervey, Dana Albaiu |
|